188 related articles for article (PubMed ID: 31107171)
41. A CRISPR edit for heart disease.
King A
Nature; 2018 Mar; 555(7695):S23-S25. PubMed ID: 29517035
[No Abstract] [Full Text] [Related]
42. Plant genome editing using xCas9 with expanded PAM compatibility.
Li J; Luo J; Xu M; Li S; Zhang J; Li H; Yan L; Zhao Y; Xia L
J Genet Genomics; 2019 May; 46(5):277-280. PubMed ID: 31054950
[No Abstract] [Full Text] [Related]
43. Cas9 immunity creates challenges for CRISPR gene editing therapies.
Crudele JM; Chamberlain JS
Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
[TBL] [Abstract][Full Text] [Related]
44. In search of: Suggesting a course of action for the scientific community to research potential impacts of heritable gene editing on the maternal carrier.
Gravelle R
Semin Perinatol; 2018 Dec; 42(8):522-524. PubMed ID: 30482592
[TBL] [Abstract][Full Text] [Related]
45. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
46. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
47. Current status and recent advances of gene therapy in hematological diseases.
Yamamoto M; Tani K
Int J Hematol; 2016 Jul; 104(1):4-5. PubMed ID: 27250344
[No Abstract] [Full Text] [Related]
48. CRISPR takes on Huntington's disease.
Eisenstein M
Nature; 2018 May; 557(7707):S42-S43. PubMed ID: 29844549
[No Abstract] [Full Text] [Related]
49. Gene therapy for sickle cell disease.
The Lancet Haematology
Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
[No Abstract] [Full Text] [Related]
50. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
Tang L; Gong M; Zhang P
Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
[TBL] [Abstract][Full Text] [Related]
51. The multiplexed CRISPR targeting platforms.
Cao J; Xiao Q; Yan Q
Drug Discov Today Technol; 2018 Aug; 28():53-61. PubMed ID: 30205881
[TBL] [Abstract][Full Text] [Related]
52. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
Carlson B
Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
[No Abstract] [Full Text] [Related]
53. Efficient generation of the mouse model with a defined point mutation through haploid cell-mediated gene editing.
Wei L; Wang X; Yang S; Yuan W; Li J
J Genet Genomics; 2017 Sep; 44(9):461-463. PubMed ID: 28943147
[No Abstract] [Full Text] [Related]
54. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
Castino G; Guillemet M; Joly A; Vignon A
Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
[No Abstract] [Full Text] [Related]
55. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
Zhang D; Li Z; Li JF
J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
[TBL] [Abstract][Full Text] [Related]
56. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
Tarasava K; Oh EJ; Eckert CA; Gill RT
Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
[TBL] [Abstract][Full Text] [Related]
57. Mosaicism in CRISPR/Cas9-mediated genome editing.
Mehravar M; Shirazi A; Nazari M; Banan M
Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
[TBL] [Abstract][Full Text] [Related]
58. [Bacterial genome editing using the CRISPR/Cas12a system].
Castagné P; Guingand A; Moderc A; Monard S
Med Sci (Paris); 2018 May; 34(5):399-400. PubMed ID: 29900839
[No Abstract] [Full Text] [Related]
59. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
60. Genome-editing technologies: the gap between application and policy.
Li G; Liu YG; Chen Y
Sci China Life Sci; 2019 Nov; 62(11):1534-1538. PubMed ID: 31686319
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
